Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Rapezzi

Showing results (81-90 of 404) with videos related to

Pageof 41
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The treatment of amyloidosis is being refinedAnna Cantone, Federico Sanguettoli, Beatrice Dal Passo, et al.
European Heart Journal|November 16, 2007
Prenatal echographic recognition of hypertrophic cardiomyopathy leading to heart transplantation in the newbornDaniela Prandstraller, Ornella Leone, Elena Biagini, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Cardiac amyloidosis: pitfalls and deceptions]Claudio Rapezzi, Letizia Riva, Cristina C Quarta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 2, 2007
Aortic thrombosis: a shared complication of different underlying diseasesClaudio Rapezzi, Ferdinando Pasquale, Elena Biagini, et al.
The American Journal of Cardiology|June 1, 2016
Effect of Cardiac Resynchronization Therapy on Left Atrial Size and Function as Expressed by Speckle Tracking 2-Dimensional StrainCinzia Valzania, Fredrik Gadler, Giuseppe Boriani, et al.
Scandinavian Cardiovascular Journal : SCJ|February 15, 2020
Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registryCinzia Valzania, Fredrik Gadler, Giuseppe Boriani, et al.
Contemporary Clinical Trials Communications|May 9, 2018
Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?Gian Piero Perna, Fabio Vagnarelli, Maurizio Volterrani, et al.
Circulation|April 5, 2017
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac AmyloidosisMathew S Maurer, Perry Elliott, Raymond Comenzo, et al.
Journal of Clinical Medicine|November 11, 2022
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In?Michele Malagù, Luca Donazzan, Andrea Capanni, et al.
The American Journal of Cardiology|May 25, 2010
Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathyRossella Fattori, Elena Biagini, Massimiliano Lorenzini, et al.
Pageof 41

Showing results (81-90 of 404) with videos related to

Sort By:
Pageof 41
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The treatment of amyloidosis is being refinedAnna Cantone, Federico Sanguettoli, Beatrice Dal Passo, et al.
European Heart Journal|November 16, 2007
Prenatal echographic recognition of hypertrophic cardiomyopathy leading to heart transplantation in the newbornDaniela Prandstraller, Ornella Leone, Elena Biagini, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Cardiac amyloidosis: pitfalls and deceptions]Claudio Rapezzi, Letizia Riva, Cristina C Quarta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 2, 2007
Aortic thrombosis: a shared complication of different underlying diseasesClaudio Rapezzi, Ferdinando Pasquale, Elena Biagini, et al.
The American Journal of Cardiology|June 1, 2016
Effect of Cardiac Resynchronization Therapy on Left Atrial Size and Function as Expressed by Speckle Tracking 2-Dimensional StrainCinzia Valzania, Fredrik Gadler, Giuseppe Boriani, et al.
Scandinavian Cardiovascular Journal : SCJ|February 15, 2020
Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registryCinzia Valzania, Fredrik Gadler, Giuseppe Boriani, et al.
Contemporary Clinical Trials Communications|May 9, 2018
Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?Gian Piero Perna, Fabio Vagnarelli, Maurizio Volterrani, et al.
Circulation|April 5, 2017
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac AmyloidosisMathew S Maurer, Perry Elliott, Raymond Comenzo, et al.
Journal of Clinical Medicine|November 11, 2022
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In?Michele Malagù, Luca Donazzan, Andrea Capanni, et al.
The American Journal of Cardiology|May 25, 2010
Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathyRossella Fattori, Elena Biagini, Massimiliano Lorenzini, et al.
Pageof 41